Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions
View Patent ↗The present application is directed to the use of X-ray contrast media that act as universal antigens that are labeled herein as “pseudoantigens.” X-ray contrast media have the potential to exist in an aggregated state that is greater in increased concentrations. In this aggregated state, contrast media assume the role of multivalent antigens and can successfully compete with any other antigens involved in antibody-antigen reactions that lead to anaphylaxis. In this competition, the large quantity of contrast media serves to inhibit the adverse effects of antibody-antigen reactions without the contrast media itself creating antibodies or creating toxicity problems.
1. A method of treating an allergic reaction in a mammal comprising the step of topically administering a therapeutically effective amount of an X-ray contrast medium to said mammal, wherein said X-ray contrast media comprises a triiodinated, benzene moiety that is completely or partially substituted, and wherein said X-ray contrast medium is a non-ionic monomer, an ionic monomer, a non-ionic dimer, or an ionic dimer.
2. The method of claim 1 , wherein the effective amount is effective to produce a decrease in histamine release.
3. The method of claim 1 , wherein the effective amount is a dosage between 0.1 grams and 40 grams of the contrast medium.
4. The method of claim 1 , wherein the effective amount is a dosage between 0.01 grams and 0.1 grams of the contrast medium.
5. The method of claim 1 , wherein the X-ray contrast medium comprises IOHEXOL.
6. The method of claim 1 , wherein the X-ray contrast medium comprises metrizamide.
7. The method of claim 1 , wherein the X-ray contrast medium comprises ioxaglate.
8. The method of claim 1 , wherein the X-ray contrast medium comprises iopamidol.
9. The method of claim 1 , wherein the X-ray contrast medium comprises iotrolan.
10. The method of claim 1 , wherein the X-ray contrast medium comprises iodixanol.
11. The method of claim 1 , wherein the X-ray contrast medium comprises ioversol.
12. The method of claim 1 , wherein the X-ray contrast medium comprises iothalamate.
13. The method of claim 1 , wherein the X-ray contrast medium comprises meglumine/sodium diatrizoate.